News, Short Squeeze, Breakout and More Instantly...
Results exceed prior first quarter guidance across all metrics Total GAAP revenues of $246 million Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a ...
FRANKLIN, Tenn., April 22, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"),...
Multi-year Innovation Program Designed to Maximize Value and Outcomes for XT Automated Dispensing System Omnicell, Inc. (Nasdaq:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced XT Amplify, a multi...